Skip to main content
Sam-A Pharm. Co. Ltd logo

Sam-A Pharm. Co. Ltd — Investor Relations & Filings

Ticker · 009300 ISIN · KR7009300005 KO Manufacturing
Open in API
Filings indexed 105 across all filing types
Latest filing 2020-02-28 AGM Information
Country KR South Korea
Listing KO 009300

About Sam-A Pharm. Co. Ltd

https://www.samapharm.co.kr/eng/main201…

Sam-A Pharm. Co. Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of a range of pharmaceutical products. The company specializes in several therapeutic areas, with a primary focus on treatments for respiratory and dermatological conditions. Its portfolio also includes antipyretic, analgesic, and anti-inflammatory medications. Founded in 1945, Sam-A Pharm. operates manufacturing facilities that adhere to high-quality production standards, equivalent to EU-GMP, reflecting its long-standing commitment to improving health and quality of life.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Sam-A Pharmaceutical. It outlines the date, location, and agenda items (financial statements, director/auditor appointments, and remuneration limits). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming votes, which falls under the Proxy Solicitation & Information Statement category.
2020-02-28 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Sam-A Pharmaceutical regarding the decision to pay a cash dividend. It specifies the dividend amount per share, the total dividend amount, the record date, and the expected payment date. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2020-02-21 Korean
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Sam-A Pharm (삼아제약) covering the period from 2019.01.01 to 2019.09.30. It contains detailed financial information, business operations, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-11-14 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Sam-A Pharm, covering the period from 2019.01.01 to 2019.06.30. It contains detailed financial information, business descriptions, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). It is not an announcement of a report (RPA) as it contains the full content of the report itself. H1 2019
2019-08-14 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Sam-A Pharm, covering the period from January 1, 2019, to March 31, 2019. It contains detailed financial data, business operations, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-15 Korean
사업보고서 (2018.12)
Audit Report / Information Classification · 97% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Sam-A Pharmaceutical Co., Ltd. for the fiscal year ending December 31, 2018. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. While it contains financial data, it is not a standalone 'Annual Report' (10-K) which typically includes management discussion and analysis (MD&A) and broader corporate governance disclosures, nor is it a quarterly report. It is a formal audit report package, which fits the 'Audit Report / Information' (AR) category. FY 2018
2019-04-01 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.